4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-17-011838
Options or other derivatives
- Chief Medical Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BARTLETT ROBERT HAWES Chief Medical Officer | 2017-02-24 | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | D | ||
Loading xslF345X03/v460711_form4.xml…